Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-beta1/Smads signaling pathway: A potential therapeutic target. Lin L, Huang S, Lin X, Liu X, et al. PLoS One 2024;19:e0309338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin L, Huang S, Lin X, Liu X, et al. Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-beta1/Smads signaling pathway: A potential therapeutic target. PLoS One 2024;19:e0309338.
PMID: 39190657